182 related articles for article (PubMed ID: 27033599)
1. Downregulation of HDAC9 inhibits cell proliferation and tumor formation by inducing cell cycle arrest in retinoblastoma.
Zhang Y; Wu D; Xia F; Xian H; Zhu X; Cui H; Huang Z
Biochem Biophys Res Commun; 2016 Apr; 473(2):600-6. PubMed ID: 27033599
[TBL] [Abstract][Full Text] [Related]
2. Hsa_circ_0000527 Downregulation Suppresses the Development of Retinoblastoma by Modulating the miR-27a-3p/HDAC9 Pathway.
Zuo X; Fu C; Xie J; Wang X; Yan Z
Curr Eye Res; 2022 Jan; 47(1):115-126. PubMed ID: 34823425
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of long non‑coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR‑3619‑5p to target HDAC9.
Zhu Y; Hao F
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33693951
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway.
Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
Oncol Rep; 2020 Feb; 43(2):635-645. PubMed ID: 31922233
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
Wu XZ; Cui HP; Lv HJ; Feng L
Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin, a mTOR inhibitor, induced growth inhibition in retinoblastoma Y79 cell via down-regulation of Bmi-1.
Wang YD; Su YJ; Li JY; Yao XC; Liang GJ
Int J Clin Exp Pathol; 2015; 8(5):5182-8. PubMed ID: 26191215
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
Xing L; Zhang L; Feng Y; Cui Z; Ding L
Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in non-small cell lung cancer after melatonin treatment.
Ma Z; Liu D; Di S; Zhang Z; Li W; Zhang J; Xu L; Guo K; Zhu Y; Li X; Han J; Yan X
J Pineal Res; 2019 Sep; 67(2):e12587. PubMed ID: 31090223
[TBL] [Abstract][Full Text] [Related]
9. Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways.
Ding Y; Wu M; Liu J; Wu C; Huang R; Zhu R; Fei J
Exp Eye Res; 2014 May; 122():1-8. PubMed ID: 24607444
[TBL] [Abstract][Full Text] [Related]
10. HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
Yang R; Wu Y; Wang M; Sun Z; Zou J; Zhang Y; Cui H
Oncotarget; 2015 Apr; 6(10):7644-56. PubMed ID: 25760078
[TBL] [Abstract][Full Text] [Related]
11. MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2.
Lei Q; Shen F; Wu J; Zhang W; Wang J; Zhang L
Oncol Rep; 2014 Jul; 32(1):261-9. PubMed ID: 24807198
[TBL] [Abstract][Full Text] [Related]
12. JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis.
Zhang Y; Duan S; Jang A; Mao L; Liu X; Huang G
Exp Eye Res; 2021 Jan; 202():108304. PubMed ID: 33080301
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
14. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
[TBL] [Abstract][Full Text] [Related]
15. Effects of lentivirus-mediated astrocyte elevated gene-1 overexpression on proliferation and apoptosis of human retinoblastoma cells.
Bai H; Chang Y; Li B; Mao Y; Jonas JB
Acta Ophthalmol; 2019 May; 97(3):e397-e402. PubMed ID: 30694025
[TBL] [Abstract][Full Text] [Related]
16. Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer.
Xiong K; Zhang H; Du Y; Tian J; Ding S
Exp Mol Med; 2019 Aug; 51(8):1-15. PubMed ID: 31451695
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis.
Rastogi B; Raut SK; Panda NK; Rattan V; Radotra BD; Khullar M
Mol Cell Biochem; 2016 Apr; 415(1-2):183-96. PubMed ID: 26992905
[TBL] [Abstract][Full Text] [Related]
18. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.
Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597
[TBL] [Abstract][Full Text] [Related]
19. Identifying targets for the restoration and reactivation of BRM.
Kahali B; Gramling SJ; Marquez SB; Thompson K; Lu L; Reisman D
Oncogene; 2014 Jan; 33(5):653-64. PubMed ID: 23524580
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
Xia T; Cheng H; Zhu Y
Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
